Nuvaira, Inc.的封面图片
Nuvaira, Inc.

Nuvaira, Inc.

医疗设备

Maple Grove,Minnesota 5,479 位关注者

Our dNerva® Lung Denervation System is an investigative COPD therapy that aims to preserve patient lung health.

关于我们

Nuvaira, Inc. develops innovative and groundbreaking therapies that aim to improve the lives of the more than 65 million people around the world with obstructive lung disease. Founded in 2008, Nuvaira was established to address clinical needs in the treatment of overactive airway nerves, a common disease feature of both COPD and asthma. Nuvaira is a privately held medical device company, headquartered in Minneapolis, Minnesota USA and has more than 75 patents issued and pending worldwide. The dNerva® Lung Denervation System is CE Mark approved. The dNerva® lung denervation system is under clinical investigation and is not commercially available in the USA.

网站
http://www.nuvaira.com
所属行业
医疗设备
规模
51-200 人
总部
Maple Grove,Minnesota
类型
私人持股
创立
2008
领域
COPD、Pulmonology、lung denervation、obstructive lung disease、Interventional Pulmonology、chronic obstructive lung disease、Bronchoscopy、Bronchology和medical devices

地点

  • 6500 Wedgewood Rd N

    US,Minnesota,Maple Grove,55311

    获取路线

Nuvaira, Inc.员工

动态

相似主页

查看职位

融资

Nuvaira, Inc. 共 11 轮

上一轮

未知

US$52,875.00

Crunchbase 上查看更多信息